Filing Flows › Comparisons › ABEO vs ASMB
Abeona Therapeutics vs Assembly Biosciences: ABEO and ASMB compared
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $13.4M for Assembly Biosciences (Q2 2026). Assembly Biosciences is more profitable, with an operating margin of -47.4% against -96.4%.
Where the money goes: ABEO and ASMB
Abeona Therapeutics (ABEO) · Q3 2026
Abeona Therapeutics, Q3 2026: revenue $13.5M, operating margin -96.4%, net loss $4.8M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
Assembly Biosciences (ASMB) · Q2 2026
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart follows the revenue to costs, profit and cash.
| Abeona Therapeutics (ABEO) | Assembly Biosciences (ASMB) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $13.5M | $13.4M |
| Revenue growth, Y/Y | — | +39% |
| Operating margin | -96.4% | -47.4% |
| Net earnings | −$4.8M | −$3.9M |
| Net margin | -35.6% | -28.8% |
| Operating cash flow | −$8.3M | −$15.5M |
Questions
Which is bigger, Abeona Therapeutics or Assembly Biosciences?
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $13.4M for Assembly Biosciences (Q2 2026).
Is Abeona Therapeutics or Assembly Biosciences growing faster?
Assembly Biosciences is more profitable, with an operating margin of -47.4% against -96.4%.
More: Abeona Therapeutics earnings · how Abeona Therapeutics makes money · Assembly Biosciences earnings · how Assembly Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.